• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Filaria journal >Defining the cost of the Egyptian lymphatic filariasis elimination programme
【24h】

Defining the cost of the Egyptian lymphatic filariasis elimination programme

机译：确定埃及消除淋巴丝虫病计划的费用

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background Lymphatic filariasis (LF) is targeted for global elimination. LF elimination programmes in different countries, including Egypt, are supported financially by national and international agencies. The national programme in Egypt is based on mass drug administration (MDA) of an annual dose of a combination of 2 drugs (DEC and albendazole) to all endemic villages. This study aimed primarily to estimate the Total and Government costs of two rounds of MDA conducted in Egypt in 2000 and 2001, the average cost per person treated, and the cost share of the different programme partners. Methods The Total costs reflect the overall annual costs of the MDA programme, and we defined Government costs as those expenditures made by the Egyptian government to develop, implement and sustain the MDA programmes. We used a generic protocol developed in coordination with the Emory Lymphatic Filariasis Support Center. Our study was concerned with all costs to the government, donors and other implementing parties. Cost data were retrospectively gathered from local, regional and national Ministry of Health and Population records. The total estimates for each governorate were based on data from a representative district for the governorate; these were combined with national programme data for a national estimate. Results The overall Total and Government costs for treating approximately 1,795,553 individuals living in all endemic villages in the year 2000 were US $3,181,000 and US $2,412,000, respectively. In 2001, the number of persons treated increased (29%) and the Total costs were US $3,109,000 while Government costs were US $2,331,000. In 2000, the average Total and Government costs per treated subject were US $1.77 and $1.34, respectively, however, these costs decreased to US $1.34 and $1.00, respectively in 2001. The coverage rate was 86.0% in 2000 and it increased to 88.0% in 2001. Conclusion The Egyptian government provided 75.8% of all resources, as reflected in the Total cost estimates, and international agencies contributed the rest. Such data highlight both the commitment of the Egyptian government and the significance of the contributions of international bodies toward the LF elimination programme.
机译：背景淋巴丝虫病（LF）的目标是全面消除。国家和国际机构在财政上支持包括埃及在内的不同国家的LF消除计划。埃及的国家计划基于大规模药物管理（MDA），即向所有流行村庄每年注射两种药物（DEC和阿苯达唑）的组合。这项研究的主要目的是估计2000年和2001年在埃及进行的两轮MDA的总费用和政府费用，每人平均治疗费用以及不同计划合作伙伴的费用份额。方法总成本反映了MDA计划的年度总成本，我们将政府成本定义为埃及政府用于制定，实施和维持MDA计划的支出。我们使用了与Emory淋巴丝虫病支持中心协作开发的通用协议。我们的研究涉及政府，捐助方和其他执行方的所有费用。费用数据是从地方，地区和国家卫生与人口部的记录中回顾性收集的。每个省的总概算是基于该省代表区的数据得出的;将这些与国家计划数据结合起来进行国家估算。结果2000年，用于治疗所有流行村庄中约1,795,553个人的总费用和政府费用分别为3,181,000美元和2,412,000美元。 2001年，接受治疗的人数有所增加（29％），总费用为3,109,000美元，而政府费用为2,331,000美元。 2000年，每个接受治疗的受试者的平均总费用和政府费用分别为1.77美元和1.34美元，但是，这些费用在2001年分别降至1.34美元和1.00美元。2000年的覆盖率为86.0％，而2000年的覆盖率为88.0％。 2001年。结论如总费用估算所示，埃及政府提供了所有资源的75.8％，其余费用由国际机构提供。这些数据既彰显了埃及政府的承诺，也彰显了国际机构对消除LF方案的贡献的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号